GPX4 and gastric cancer: In conclusion, the GPX4 protein is linked to the occurrence and progression of gastric cancer, as well as gastric cancer chemodrug resistance and patient prognosis, and targeted GPX4 blockade improves gastric cancer chemosensitivity and overall survival rate.